The no-reflow phenomenon has been studied extensively in the basic science laboratory
and has entered the clinical arena. No-reflow, which develops largely within the first 2h of …

A large number of studies has demonstrated that abnormalities of coronary microcirculation
may be responsible for both acute and chronic cardiac ischemic syndromes. In clinical …

Fluorinated components useful for organizing space at the molecular, nanometer and
micrometer scales include perfluorocarbons, perfluoroalkylated surfactants and …

Objective: To identify in humans the temporal patterns of no reflow and their functional
implications. Methods: 24 patients with first acute myocardial infarction and successful …

Microvascular permeabilization, petechial hemorrhage and premature ventricular
contractions (PVCs) have been demonstrated in an in vivo rat model of myocardial contrast …

Objectives: The aim of this study was to clarify the role of microembolization in the genesis of
microvascular obstruction (MO) after percutaneous coronary intervention (PCI). Background …

An oxygen carrying, heat-sterilized phospholipid-based emulsion of a fast excreted lipophilic
fluorocarbon, perfluorooctyl bromide (perflubron), stabilized against molecular diffusion, has …

There is an increasing interest in the role of echocardiography in the evaluation of primary
microvascular angina, which is attributed to primary coronary microvascular dysfunction …

Background—The purpose of this study was to verify whether endothelin A–antagonist
administration at the time of coronary reperfusion preserves postischemic microvasculature …

Up to 60–70% of patients, undergoing invasive coronary angiography due to angina and
demonstrable myocardial ischemia with provocative tests, do not have any obstructive …